We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$2.47B
Cap. Flow %
-43.88%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Technology 7.29%
3 Consumer Discretionary 4.25%
4 Communication Services 1.58%
5 Consumer Staples 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEHC icon
101
GE HealthCare
GEHC
$28.7B
$8.42M 0.15%
118,289
-673,711
-85% -$53.1M
MU icon
102
Micron Technology
MU
$959B
$7.87M 0.14%
+23,293
New +$9.12M
TENX icon
103
Tenax Therapeutics
TENX
$420M
$7.66M 0.14%
+478,827
New +$6.48M
NUVB icon
104
Nuvation Bio
NUVB
$2.02B
$7.45M 0.13%
1,736,000
+472,263
+37% +$2.63M
INGN icon
105
Inogen
INGN
$178M
$7.42M 0.13%
1,200,000
-64,000
-5% -$395K
ORLY icon
106
O'Reilly Automotive
ORLY
$71.3B
$7.21M 0.13%
78,103
-13,008
-14% -$1.22M
KYMR icon
107
Kymera Therapeutics
KYMR
$9.52B
$6.99M 0.12%
83,876
+2,711
+3% +$215K
DWTX
108
Dogwood Therapeutics
DWTX
$46.4M
$6.92M 0.12%
+3,280,000
New +$9.65M
RH icon
109
RH
RH
$3.56B
$6.71M 0.12%
48,000
-67,000
-58% -$12.2M
NVST icon
110
Envista
NVST
$4.35B
$6.7M 0.12%
+264,008
New +$6.85M
ICLR icon
111
Icon
ICLR
$13.1B
$6.67M 0.12%
+60,268
New +$8.23M
ULTA icon
112
Ulta Beauty
ULTA
$20.6B
$6.66M 0.12%
12,736
+5,905
+86% +$3.76M
DVA icon
113
DaVita
DVA
$15.2B
$6.61M 0.12%
+42,978
New +$5.83M
BE icon
114
Bloom Energy
BE
$61.1B
$6.47M 0.12%
47,737
+43,346
+987% +$6.36M
BL icon
115
BlackLine
BL
$1.78B
$6.22M 0.11%
+168,000
New +$7.24M
SYRE icon
116
Spyre Therapeutics
SYRE
$8.7B
$6.1M 0.11%
120,931
-75,495
-38% -$2.85M
RBLX icon
117
Roblox
RBLX
$37B
$5.9M 0.1%
104,292
+63,251
+154% +$4.25M
EOLS icon
118
Evolus
EOLS
$377M
$5.74M 0.1%
1,396,000
+420,000
+43% +$2.04M
CTOR
119
Citius Oncology
CTOR
$64.1M
$5.7M 0.1%
9,188,855
+3,604,775
+65% +$3.62M
AMAT icon
120
Applied Materials
AMAT
$421B
$5.64M 0.1%
+16,503
New +$5.55M
LRCX icon
121
Lam Research
LRCX
$392B
$5.12M 0.09%
+23,952
New +$5.36M
PONY
122
Pony AI Inc
PONY
$2.89B
$5.06M 0.09%
536,000
+68,000
+15% +$937K
LCTX icon
123
Lineage Cell Therapeutics
LCTX
$289M
$5.03M 0.09%
+3,182,799
New +$5.37M
AS icon
124
Amer Sports
AS
$21.2B
$4.9M 0.09%
148,770
-36,437
-20% -$1.33M
WDC icon
125
Western Digital
WDC
$164B
$4.84M 0.09%
+17,885
New +$4.67M
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.